Industry: Healthcare | Pharmaceutical | Biotech
Using Riverbed®, GSK experienced a 50 percent decrease in overall network traffic.
Headquartered in the United Kingdom, GlaxoSmithKline (GSK) is Europe’s largest pharmaceutical manufacturer and the third largest company of its kind in the world. When GSK decided to move its internally hosted messaging infrastructure to an externally hosted Microsoft platform, improving the performance of its network and collaboration environment was a core requirement.
GSK turned to Riverbed to meet this critical demand. With Riverbed, GSK has not only been able to reduce traffic, but has also gained complete visibility into network performance across the enterprise.
Riverbed delivers the most complete platform for Location-Independent Computing, turning location and distance into a competitive advantage. The Riverbed Application Performance Platform™ allows IT to have the flexibility to host applications and data in the most optimal locations while ensuring applications perform as expected, data is always available when needed, and performance issues are detected and fixed before end users notice. At more than $1 billion in annual revenue, Riverbed has 25,000+ customers, including 97% of both the Fortune 100 and the Forbes Global 100.